Oncimmune Holdings plc (ONC) Ordinary 1p
- Add to watchlist
- Create an alert
- This stock can be held in a
n/a
n/a
44.00p
£15.72 million
21.20p
n/a
13.00p
n/a
0.20p (0.95%) Previous:
0.20p
n/a
n/a
10,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/08/2023 | 31/08/2022 |
---|---|---|
Revenue (£m) | 1.15 | 2.32 |
Profit before tax (£m) | (5.93) | (6.58) |
Adjusted EPS (p): | (8.47) | (7.91) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Oncimmune revenue falls as it implements new strategy
29 February 2024 13:04
-
Oncimmune sells 'non-core' lung and antibody assets in £13m deal
22 May 2023 11:14
-
Oncimmune enters collaboration with Siemens Healthineers
17 February 2023 15:53
-
Holding(s) in Company
26 March 2024 11:18
-
Block Listing Return
13 March 2024 17:32
-
Posting of Notice of General Meeting
6 March 2024 15:02
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.